EMA workshop: Non-clinical data for regulatory decision-making on the efficacy of medical countermeasures held the 25 and 25 November: presentation materials and video recordings of the event are now available

Read full text Summarise with VIRAT
Authors: vroby
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The increase in global emergencies and the need to prepare for health threats - from emerging infectious diseases to bioterrorism, radiological, nuclear and chemical threats (CBRN) - advocates for regulatory and scientific pathways for licensing medical countermeasures (MCMs) when human efficacy trials are not feasible or not ethical. The workshop is focusing on discussing the current regulatory frameworks for the approval of MCMs against these threats based on non-clinical data (usually ani...

Fields of Study & Subjects

Animal testing and alternatives Agricultural safety and regulations Biomedical Ethics and Regulation

Publication details

Journal / source
Hypotheses (OpenEdition)
Publication date
28 March 2026
Language
EN